Palatin Technologies, Inc. Common Stock (PTN)

Palatin Technologies, Inc. Common Stock (PTN) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $9.9M; returns 1 day -7.3%, 1 week -15.1%, 1 year -13.4%.

Palatin Technologies Inc. (PTN) is a biopharmaceutical company focused on developing first-in-class medicines based on molecules that modulate the melanocortin receptor (MCR) system. Their strategy is to develop products and then form marketing collaborations with industry leaders to maximize their commercial potential.

Groups PTN belongs to

• Biotechnology
• Biopharmaceutical
• Healthcare
• Life Sciences
• Clinical Stage
• Clinical Stage Biopharma
• R&D
• Drug Discovery
• Ophthalmology

PTN financial model: income statement, cash flow and balance sheet